From AVAC <[email protected]>
Subject Apr 2 Webinar—Pandemic Vaccine Development and Lessons for COVID-19
Date March 26, 2020 7:55 PM
  Links have been removed from this email. Learn more in the FAQ.
  Links have been removed from this email. Learn more in the FAQ.
------------------------------------------------------------
[link removed]


** Apr 2 Webinar—Pandemic Vaccine Development and Lessons for COVID-19
------------------------------------------------------------
March 26, 2020

Dear Advocate,

Please join an upcoming webinar on pandemic vaccine development, scheduled for Thursday, April 2, 10am EDT.

In the second installment of AVAC’s webinar series on COVID-19 and its relationship to HIV, Dr. ([link removed]) Mark ([link removed]) ([link removed]) Feinberg ([link removed]) , CEO of IAVI ([link removed]) , will share experiences and lessons from Ebola and HIV vaccine development that might be applied to COVID-19 vaccine development. Dr. Feinberg will also describe the history and role of the Coalition for Epidemic Preparedness Innovations (CEPI ([link removed]) ), which supports vaccine development against emerging infectious diseases, including COVID-19.

REGISTER HERE. ([link removed])

The first webinar in the series featured a range of voices on COVID-19 and HIV. Dr. Carl Dieffenbach, Director of the Division of AIDS (DAIDS) at the US NIH ([link removed]) answered questions about risk for people living with HIV, the impact of COVID-19 on HIV research, and the status of research into treatments and vaccines for COVID-19. Lillian Mworeko of ICW-EA ([link removed]) and Yvette Raphael of APHA ([link removed]) [link removed] issues that must be incorporated into a robust advocacy agenda for sub-Saharan Africa, a region bracing for a tide of COVID-19 cases already seen in Asia, Europe and North America. The advocates also shared their Call to African leaders to accelerate action on COVID-19 ([link removed]) .

Additional Resources
* Our partners at the Global Health Technologies Coalition (GHTC ([link removed]) ) have a COVID-19 R&D Tracker ([link removed]) . It summarizes the latest updates on:
+ US government-supported R&D for SARS-CoV-2 ([link removed])
+ Efforts led by multilateral institutions ([link removed])
+ R&D being led by GHTC members ([link removed])
+ Other efforts by GHTC members to respond to the pandemic ([link removed])


* AVAC maintains a Resources for Advocates ([link removed]) sheet that provides links to the latest COVID-19 information on prevention and transmission, the research pipeline, and a growing list of country-specific resources.


While there is anxiety and uncertainty right now, we take great comfort in our relationships, knowing we have each other for support, solace and motivation. Thank you, as ever, for your partnership and commitment to our important work together.

Best,
AVAC

============================================================
Forward This Issue Do you know someone who might be interested in receiving this newsletter?
** Forward > ([link removed])

Unsubscribe You're receiving this because you signed up for our newsletter. Not interested any longer?
** Unsubscribe > ([link removed])

Contact Us T: +1 212 796 6423
E: ** [email protected] (mailto:[email protected])
W: ** www.avac.org ([link removed])
** ([link removed])
** ([link removed])
** ([link removed])
Screenshot of the email generated on import

Message Analysis